Financial

CLINUVEL
Posted by CLINUVEL
February 24, 2023

Appendix 4D Half Yearly Report

Melbourne, Australia, 24 February 2023 ASX: CUV Börse Frankfurt: UR9 ADR Level...

Read More
CLINUVEL
Posted by CLINUVEL
January 31, 2023

Appendix 4C & Activity Report

Melbourne, Australia, 31 January 2023 ASX: CUV Börse Frankfurt: UR9 ADR Level...

Read More
CLINUVEL
Posted by CLINUVEL
December 21, 2022

Notification of cessation of securities

Melbourne, Australia, 21 December 2022 ASX: XETRA-DAX: ADR Level 1: CUV UR9...

Read More
CLINUVEL
Posted by CLINUVEL
November 7, 2022

Appendix 3Y - Change of Director’s Interest Notice

Melbourne, Australia, 07 November 2022 ASX: XETRA-DAX: Level 1 ADR: CUV UR9...

Read More
CLINUVEL
Posted by CLINUVEL
October 31, 2022

Appendix 4C & Activity Report

CLINUVEL PHARMACEUTICALS LTD today released its Appendix 4C – Quarterly Cashflow Report...

Read More
CLINUVEL
Posted by CLINUVEL
October 26, 2022

Results of Annual General Meeting 2022

In accordance with Listing Rule 3.13.2 and section 251AA of the Corporations...

Read More
CLINUVEL
Posted by CLINUVEL
September 8, 2022

CLINUVEL confirms AGM date

CLINUVEL confirms the date for the Company’s 2022 Annual General Meeting.

Read More
CLINUVEL
Posted by CLINUVEL
August 31, 2022

CLINUVEL Investor Webinar Financial Results Year Ended 30 June 2022

CLINUVEL PHARMACEUTICALS LTD hosted an investor webinar on the financial results for...

Read More
CLINUVEL
Posted by CLINUVEL
August 30, 2022

Appendix 4G

CLINUVEL PHARMACEUTICALS LTD today released its Appendix 4G

Read More
CLINUVEL
Posted by CLINUVEL
August 30, 2022

Revenue Growth Drives CLINUVEL's Sixth Consecutive Annual Profit

CLINUVEL today announced its sixth consecutive annual net profit, driven by revenues...

Read More
CLINUVEL
Posted by CLINUVEL
August 30, 2022

Dividend/Distribution – CUV

CLINUVEL PHARMACEUTICALS LTD today released its Appendix 4E and Annual Report

Read More
CLINUVEL
Posted by CLINUVEL
August 30, 2022

Appendix 4E & Annual Report

CLINUVEL PHARMACEUTICALS LTD today released its Appendix 4E and Annual Report

Read More
CLINUVEL
Posted by CLINUVEL
July 25, 2022

Appendix 4C & Activity Report

CLINUVEL PHARMACEUTICALS LTD today released its Appendix 4C – Quarterly Cashflow Report...

Read More
CLINUVEL
Posted by CLINUVEL
June 23, 2022

Change of Director’s Interest Notice

Melbourne, Australia, 23 June 2022 ASX: XETRA-DAX: ADR Level 1: CUV UR9...

Read More
CLINUVEL
Posted by CLINUVEL
June 14, 2022

Change of Director’s Interest Notice

Melbourne, Australia, 14 June 2022 ASX: XETRA-DAX: ADR Level 1: CUV UR9...

Read More